ProMIS Neurosciences, Inc. (PMN)
EBITDA Margin
521254.70%
TTM · Period ending:
PMN EBITDA Margin
Latest reported521254.70%period ending
Latest reported521254.70%period ending
PMN TTM EBITDA Margin (-4019.40% → 521254.70%)
TTM ebitda margin
High-resolution chart · PNG
PMN ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 521,254.698% | |
| 662,113.3509% | |
| 670,768.8399% | |
| -2,454,296.9979% | |
| -173,408.0543% | |
| -62,352.3232% | |
| -39,717.1319% | |
| -43,056.2736% | |
| -49,276.5653% | |
| -292,982.607% | |
| -360,823.3866% | |
| -232,057.2823% | |
| -219,599.0102% | |
| -476,708.4422% | |
| -545,137.188% | |
| -1,819,407.0737% | |
| -1,441,074.4464% | |
| -1,524,458.4358% | |
| -1,271,814.3724% | |
| -1,370,324.1519% | |
| -54,432.224% | |
| -51,809.2231% | |
| -46,602.3686% | |
| -46,919.6801% | |
| -444,170.5275% | |
| -357,444.1483% | |
| -95,456.819% | |
| -149,615.3581% | |
| -22,379.8907% | |
| -17,165.395% | |
| -8,045.3627% | |
| -1,882.3563% | |
| -1,245.3148% | |
| -882.8997% | |
| -906.9117% | |
| -964.8599% | |
| -1,026.6001% | |
| -1,509.6149% | |
| -1,650.1723% | |
| -2,015.5921% | |
| -2,744.939% | |
| -4,596.874% | |
| -11,814.3671% | |
| -11,350.1192% | |
| -224.3572% | |
| -212.8911% | |
| -212.3682% | |
| -221.1977% | |
| -176.3234% | |
| -262.1567% | |
| -307.3841% | |
| -315.0457% | |
| -3,145.1996% | |
| -2,608.8827% | |
| -2,325.2592% | |
| -2,500.4366% | |
| -2,141.8677% | |
| -2,010.5716% | |
| -1,879.5606% | |
| -2,479.7944% | |
| -2,216.7037% | |
| -1,922.9299% | |
| -2,003.9018% | |
| -1,554.6303% | |
| -1,510.894% | |
| -1,641.811% | |
| -1,561.6172% | |
| -1,840.7304% | |
| -2,452.7763% | |
| -4,019.4007% |